Global Sexually Transmitted Disease (STD) Testing Market 2024-2028

Sexually Transmitted Disease (STD) Testing Market 2024-2028

The sexually transmitted disease (STD) testing market is forecasted to grow by USD 32.37 bn during 2023-2028, accelerating at a CAGR of 5.6% during the forecast period. The report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of STDs, presence of favorable reimbursement policies, and increased initiatives by governments worldwide.

Technavio's sexually transmitted disease (STD) testing market is segmented as below:

• By Product
• Laboratory testing device
• POC testing device
• By Disease Type
• Chlamydia
• Gonorrhea
• Syphilis
• Trichomoniasis
• Others
• By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in rapid diagnosis of STDs as one of the prime reasons driving the sexually transmitted disease (STD) testing market growth during the next few years. Also, increasing involvement of various organizations to create awareness about STDs and expedited partner therapy (EPT) will lead to sizable demand in the market.

The report on the sexually transmitted disease (STD) testing market covers the following areas:

• Sexually transmitted disease (STD) testing market sizing
• Sexually transmitted disease (STD) testing market forecast
• Sexually transmitted disease (STD) testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted disease (STD) testing market vendors that include AbbVie Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Goffin Molecular Technologies, Hangzhou Biotest Biotech, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., LT Labs, Merck and Co. Inc., Ok Biotech Co Ltd., Priority STD Testing, QIAGEN NV, and RayBiotech Life Inc.. Also, the sexually transmitted disease (STD) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.